Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soprano, D. R.
Right arrow Articles by Soprano, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soprano, D. R.
Right arrow Articles by Soprano, K. J.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:277S-281S, January 2003


Symposium: Advances in Retinoid Research: Mechanisms of Cancer Chemoprevention

Pharmacological Doses of Some Synthetic Retinoids Can Modulate Both the Aryl Hydrocarbon Receptor and Retinoid Receptor Pathways1,2

Dianne Robert Soprano*,{dagger}3 and Kenneth J. Soprano{dagger},**

Department of Biochemistry, * Fels Institute for Cancer Research and Molecular Biology {dagger} and Department of Microbiology and Immunology, ** Temple University School of Medicine, Philadelphia, PA 19140

3To whom correspondence should be addressed. E-mail: dsoprano{at}nimbus.temple.edu.

Retinoids have been demonstrated to have pharmacological application in the areas of dermatology and oncology. In addition to the natural retinoids such as all-trans-retinoic acid and 9-cis-retinoic acid, many new potential retinoid drugs have been synthesized, including retinoic acid receptor (RAR)-subtype selective agonists, retinoid X receptor (RXR)-selective agonists, RAR-selective antagonists, anti-AP1-specific retinoids and retinoids that induce apoptosis. Recent studies demonstrate that some retinoids, in addition to modulating the RAR/RXR pathway, are also capable at pharmacological concentrations of binding to aryl hydrocarbon receptor (AhR) and activating the AhR/AhR nuclear translocator pathway. Future studies are necessary to ascertain the consequences, if any, of activation of the AhR signaling pathway by pharmacological doses of specific retinoids.


KEY WORDS: • aryl hydrocarbon receptor • AhR nuclear translocator • retinoic acid receptor • retinoids • retinoid X receptor




This article has been cited by other articles:


Home page
J. Nutr.Home page
A. C. Ross
Advances in Retinoid Research: Mechanisms of Cancer Chemoprevention Symposium Introduction
J. Nutr., January 1, 2003; 133(1): 271S - 272.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by American Society for Nutrition